Similar articles for PMID: 20080890

Year	Number of Results
1985	1
1986	1
1988	1
1990	1
1993	2
1995	4
1996	3
1997	1
1998	1
2001	2
2003	2
2004	2
2005	1
2006	8
2007	8
2008	11
2009	11
2010	10
2011	3
2012	3
2013	5
2014	2
2015	5
2016	4
2017	4
2018	3
2019	3
2020	3
2021	2
2022	2
2023	1
2024	0

1

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

Nguyen NC, Bhatla D, Osman MM. Nguyen NC, et al. J Nucl Med. 2010 Feb;51(2):330-1; author reply 331. doi: 10.2967/jnumed.109.069781. Epub 2010 Jan 15. J Nucl Med. 2010. PMID: 20080890 Free article. No abstract available.

2

123I-MIBG versus 18F-FDG: which is better, or which can be eliminated?

Heston TF. Heston TF. J Nucl Med. 2010 Feb;51(2):330; author reply 331. doi: 10.2967/jnumed.109.069401. Epub 2010 Jan 15. J Nucl Med. 2010. PMID: 20080883 Free article. No abstract available.

3

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. Sharp SE, et al. J Nucl Med. 2009 Aug;50(8):1237-43. doi: 10.2967/jnumed.108.060467. Epub 2009 Jul 17. J Nucl Med. 2009. PMID: 19617326 Free article.

4

18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.

Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB. Papathanasiou ND, et al. J Nucl Med. 2011 Apr;52(4):519-25. doi: 10.2967/jnumed.110.083303. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421719 Free article.

5

PET/CT imaging in neuroblastoma.

Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A. Piccardo A, et al. Q J Nucl Med Mol Imaging. 2013 Mar;57(1):29-39. Q J Nucl Med Mol Imaging. 2013. PMID: 23474633 Review.

6

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. Shulkin BL, et al. Radiology. 1996 Jun;199(3):743-50. doi: 10.1148/radiology.199.3.8637999. Radiology. 1996. PMID: 8637999 Clinical Trial.

7

[Neuroblastoma staging: discrepancies between ¹⁸F-FDG-PET and ¹²³I-MIBG].

Mena LM, Muros MA, Palacios H, Moreno MJ, Santiago A, Llamas JM. Mena LM, et al. An Pediatr (Barc). 2010 Dec;73(6):363-4. doi: 10.1016/j.anpedi.2010.07.009. An Pediatr (Barc). 2010. PMID: 20817583 Free article. Spanish. No abstract available.

8

[Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].

Jotoku M, Okura T, Nagao T, Enomoto D, Irita J, Miyoshi K, Kurata M, Fukuoka T, Higaki J. Jotoku M, et al. Nihon Jinzo Gakkai Shi. 2009;51(5):563-8. Nihon Jinzo Gakkai Shi. 2009. PMID: 19715165 Japanese.

9

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK. Taggart DR, et al. J Clin Oncol. 2009 Nov 10;27(32):5343-9. doi: 10.1200/JCO.2008.20.5732. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805691 Free PMC article.

10

Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.

Mc Dowell H, Losty P, Barnes N, Kokai G. Mc Dowell H, et al. Pediatr Blood Cancer. 2009 Apr;52(4):552. doi: 10.1002/pbc.21859. Pediatr Blood Cancer. 2009. PMID: 19058210 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year